Morgan Stanley Sanara Med Tech Inc. Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Morgan Stanley holds 21,113 shares of SMTI stock, worth $621,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,113
Previous 16,064
31.43%
Holding current value
$621,355
Previous $495,000
21.01%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding SMTI
# of Institutions
50Shares Held
1.06MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$5.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$5.18 Million0.0% of portfolio
-
Stonebridge Wealth Management, LLC Oak Brook, IL115KShares$3.37 Million3.12% of portfolio
-
Geode Capital Management, LLC Boston, MA77.7KShares$2.29 Million0.0% of portfolio
-
Marshall Wace, LLP London, X071.5KShares$2.1 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $244M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...